4.4 Article

Compositional and functional differences in human gut microbiome with respect to equol production and its association with blood lipid level: a cross-sectional study

Journal

GUT PATHOGENS
Volume 11, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s13099-019-0297-6

Keywords

Equol phenotype; Gut microbiota; Blood lipid; Soy isoflavone; Dyslipidemia

Funding

  1. National Natural Science Foundation of China [81573129, 81172653, 31471203]
  2. Key Research Program of Chinese Academy of Science [KFZD-SW-219]
  3. China National key research and development plan project [2017YFD0400602]
  4. Beijing Natural Science Foundation [Z140001]
  5. 1000 Talent program of China

Ask authors/readers for more resources

BackgroundGut microbiota affects lipid metabolism interactively with diet. Equol, a metabolite of isoflavones produced by gut bacteria, may contribute substantially in beneficial lipid-lowering effects. This study aimed to examine equol production-related gut microbiota differences among humans and its consequent association with blood lipid levels.ResultsCharacterization of the gut microbiota by deep shotgun sequencing and serum lipid profiles were compared between equol producers and non-producers. Gut microbiota differed significantly at the community level between equol producers and non-producers (P=0.0062). At the individual level, 32 species associated with equol production were identified. Previously reported equol-producing related species Adlercreutzia equolifaciens and Bifidobacterium bifidum showed relatively higher abundance in this study in equol producers compared to non-producers (77.5% vs. 22.5%; 72.0% vs. 28.0%, respectively). Metabolic pathways also showed significant dissimilarity between equol producers and non-producers (P=0.001), and seven metabolic pathways were identified to be associated with the equol concentration in urine. Previously reported equol production-related gene sequences in A. equolifaciens 19450T showed higher relative abundance in equol producers than in non-producers. Additionally, we found that equol production was significantly associated with the prevalence of dyslipidemia, including a marginal increase in serum lipids (27.1% vs. 50.0%, P=0.02). Furthermore, equol production was not determined by intake of soy isoflavones, which suggested that gut microbiota is critical in the equol production process.ConclusionBoth content and functioning of the microbial gut community significantly differed between equol producers and non-producers. Further, equol producers showed lower prevalences of dyslipidemia, which suggests the important role that equol might play in lipid metabolism by gut microbiota.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available